Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

343
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
343
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

313
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
313

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Incidence, predictors and outcomes following primary graft dysfunction after cardiac transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Compassionate Use of Hypothermic Oxygenated Perfusion for Donor Hearts: Extending the Boundaries of Heart Recipient Complexity in Heart Transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Heart recipient outcomes following transplantation of donor hearts with impaired versus normal function: a study protocol for IMPROVED Heart, a prospective multicentre observational study.

BMJ open·2026
Same author

Geographical, institutional and workplace variability in genetic evaluation, screening practices, multidisciplinary care, and lung transplantation management for familial interstitial lung disease.

BMC pulmonary medicine·2026
Same author

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2026 Annual Pediatric Heart Transplantation Report, Trends and Post-transplant Outcomes by Recipient Sex.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Menopausal hormone therapy prescription and ovary-sparing surgery in women with pre-menopausal endometrial cancer: a Swedish PremEnCa study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Related Experiment Video

Updated: Jun 12, 2025

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

13.9K

Malignancies After Heart Transplantation.

Caroline Stenman1, Andreas Wallinder1,2, Erik Holmberg3,4

  • 1Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.

Transplant International : Official Journal of the European Society for Organ Transplantation
|September 24, 2024
PubMed
Summary

Heart transplant recipients face a significantly higher cancer risk, with a 6.2-fold excess risk compared to the general population. Excluding non-melanoma skin cancers, the risk remains elevated at 2.9-fold.

Keywords:
cancercohort studyepidemiologyheart transplantationsingle center study

More Related Videos

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

3.2K
Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

16.9K

Related Experiment Videos

Last Updated: Jun 12, 2025

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

13.9K
A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

3.2K
Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

16.9K

Area of Science:

  • Transplantation Medicine
  • Oncology
  • Epidemiology

Background:

  • Heart transplant (HTx) recipients have a known increased risk of developing cancer.
  • Long-term surveillance is crucial for managing post-transplant complications.

Purpose of the Study:

  • To quantify the cancer risk in heart transplant recipients.
  • To identify specific risk factors for different cancer types after HTx.
  • To compare survival outcomes for HTx patients with and without prior cancer history.

Main Methods:

  • Retrospective cohort study of 664 heart transplant patients (1985-2017).
  • Cancer diagnoses identified via Swedish Cancer-Registry and Cause-of-Death-Registry.
  • Median follow-up of 7.7 years, with cancer incidence and survival analyzed.

Main Results:

  • 19% of HTx recipients developed cancer during follow-up.
  • Standardized Incidence Ratio (SIR) for cancer was 6.2-fold higher than the general population (2.9-fold excluding NMSC).
  • Common malignancies included NMSC, non-Hodgkin lymphoma, and lung cancer. Risk factors varied by cancer type.

Conclusions:

  • Heart transplantation is associated with a substantially increased risk of malignancy.
  • Identifying specific risk factors can aid in targeted cancer prevention strategies for HTx patients.
  • Prior cancer history did not significantly impact overall survival in selected HTx recipients.